Several studies have implicated alterations in glutamatergic and/or GABAergic neurotransmission in FXS [13,14,15], supporting the notion that loss of FMRP results in aberrant mGluR5 signaling pathways. This evidence concerns the gene GRM5 and fragile X syndrome.